Clinical Trials Search

Titlesort ascending Intervention NCT ID Sponsor Status
Reproductive Health Program in Patients With Cancer Standard practice related to reproductive heath, Training modules, algorithm, referral development NCT01806129 ECOG-ACRIN Cancer Research Group Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program Health Promotion and Education, Informational Intervention, Questionnaire Administration, Smoking Cessation Intervention NCT05008848 Alliance for Clinical Trials in Oncology Recruiting
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who... Laboratory Biomarker Analysis, Trastuzumab, Whole Breast Irradiation NCT00769379 National Cancer Institute (NCI) Active, not recruiting
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection... Best Practice, Entecavir, Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate NCT03887702 Southwest Oncology Group Active, not recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Active, not recruiting
Prevention of Oral DNA Damage by Black Raspberries BRB Lozenges NCT04372914 Milton S. Hershey Medical Center Recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 ETOP IBCSG Partners Foundation Active, not recruiting
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... Denosumab, Salpingo-Oophorectomy NCT03382574 National Cancer Institute (NCI) Recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration NCT03317405 National Cancer Institute (NCI) Active, not recruiting

Pages